ReviewExpert opinion on therapeutic targets2021
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.
Dhriti Kaushik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it